§ Funding Round
Series B funding round for Nucleai raising $33M in March 2022
Series B funding round for Nucleai raising $33M in March 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Andreessen Horowitz | — | — |
| Organization | — | |
Buckley Ventures | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | noga yerushalmi | |
| Organization | — | |
| Organization | — | |
Omega Funds | — | — |
| Organization | — | |
Sanofi VenturesLEAD | Organization | — |
Section 32LEAD | Organization | — |
| Organization | — | |
| Organization | — | |
Vertex Ventures Israel | — | — |
| Organization | — | |
| Angel | harry hurst | |
| Angel | Oliver Cameron | |
| Angel | scott-belsky | |
| Angel | Yevgeny Dibrov | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$75M
Top Valuation
-
Nucleai raised $33M in a Series B round.
The round was announced on 03/01/22.
The round was led by Sanofi Ventures, Section 32.
